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Abstract
Background: Mental disorders often have onset early in life, contribute substantially to the global disease burden,
and may interfere with young people’s ability to complete age-relevant tasks in important developmental periods.
However, knowledge about prevalence and course of mental disorders in young adulthood is sparse. The aim of
the current study was to estimate prevalence and stability of mental disorders from the twenties to the
thirties/forties.
Methods: DSM-IV mental disorders were assessed with the Composite International Diagnostic Interview in two
waves (1999–2004 and 2010–2011) in 1623 young adult Norwegian twins (63.2% women, aged 19–29 years in wave 1).
Results: In wave 1, the 12-month prevalence of any mental disorder among people in the twenties was 19.8% (men)
and 32.4% (women), anxiety disorders: 9.6% (men) and 26.7% (women), anxiety disorders excluding specific phobias: 2.5%
(men) and 6.9% (women), major depressive disorder (MDD): 4.4% (men) and 7.2% (women), and alcohol use disorder
(AUD): 8.7% (men) and 4.4% (women). The prevalence of any mental disorder decreased from the twenties to the thirties/
forties. This was due to a decrease in AUD and specific phobias. Anxiety disorders in the twenties predicted anxiety
disorders and MDD ten years later, even when controlling for the association between these disorders in the twenties.
MDD in the twenties predicted MDD ten years later. At both ages, two-week and 12-month prevalence estimates differed
markedly for MDD - indicating an episodic course.
Conclusions: Common mental disorders are highly prevalent among young adults in the twenties, and somewhat less
prevalent in the thirties/forties. Those who suffer from one mental disorder in the twenties are at considerably increased
risk for suffering from a disorder ten years later as well. This may have significant implications for young people’s ability to
attain education, establish a family, and participate in occupational life.
Keywords: Mental disorders, Young adulthood, Health surveys, Prevalence, Stability
Background
Mental disorders are among the most prevalent health
problems affecting the adult population [1]. The Global
Burden of Disease Study 2015 (GBD 2015) estimated
that seven of the top 25 causes of years lived with dis-
ability (YLD) globally were mental disorders, with major
depressive disorder (MDD) ranked second and anxiety
disorders ranked ninth [2]. The high rankings were a re-
sult of both high prevalence and the disability associated
with these disorders. Estimates of 12-month prevalence
of mental disorders vary between 9.6 and 27.8% in the
general adult population [3–8]. Mood disorders, anxiety
disorders (including specific phobias), and alcohol use
disorders (AUD) are the most prevalent disorders and
are included in all the above-mentioned studies.
Young adulthood
The shift in recent decades toward longer educations and
higher age when committing to stable relationships and
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having children, has led researchers to aknowledge the age
between 18 and 29 as an important developmental period
[9]. It is characterized by changes in love and work life,
and frequent residental change [9, 10]. Completing educa-
tion and building a stable life structure are important
developmental tasks in this period, while raising children
is an important task for later periods [9, 10].
Mental health problems are associated with poor
educational attainment as well as work and interpersonal
problems [11–18]. Research results indicate that half of
US adolescents’ failure to complete secondary school is
attributable to mental disorders [19]. Mental disorders
are also associated with maladaptive parenting behaviors,
such as low affection toward the child and inconsistent
enforcement of rules [20]. Because mental disorders may
interfere with developmental tasks in different periods,
we need to increase our knowledge about the prevalence
and stability of such disorders at different ages to be able
to correctly assess the magnitude of this problem.
Prevalence of mental disorders in young adulthood
Findings from the New Zealand Mental Health Survey
(NZMHS), the Dutch Tracking Adolescents’ Individual
Lives Survey (TRAILS), the US National Comorbidity
Survey (NCS) and its replication (NCS-R), and the
Children in the Community Study (CICS) from the US,
show 12-month prevalence estiatmes of MDD between
8.3 and 12.4% among people between 18 and 33 years
[16, 21–23]. The 12-month prevalence was between 19.4
and 22.3% for anxiety disorders (including specific
phobias), between 2.5 and 10.3% for acohol dependence,
and between 7.1 and 18.4% for alcohol abuse [21–23].
Stability of mental disorders in young adulthood
Previous studies indicate that the prevalence of depression
is stable over the earliest part of adulthood, whereas AUD
decreases, and findings regarding anxiety disorders are
mixed [21, 24]. In the Dunedin study from New Zealand,
the 12-month prevalence of MDD was 16.8% at age
21 years and 16.3% at 32 years [21]. The 12-month preva-
lence of any anxiety disorder (including specific phobias)
was 20.3% at 21 years and 22.2% at 32 years. In the
Simmons Longitudinal Study from the US, prevalence
estiamtes of MDD showed a weak and not statistically sig-
nificant increase from age 21 to 30 (from 5.4 to 8.0%),
while there was a decline in the 12-month prevalence for
phobia (including specific phobias) (from 16.8 to 2.3%)
[24]. The prevalence of alcohol dependence declined
(from 18.4 to 8.1%) from age 21 to 32 in the Dunedin
study, and the prevalence of AUD declined from 26.7 to
6.0% in the Simmons Longituidnal Study [21, 24].
Some people have long-lasting and/or recurrent epi-
sodes of mental disorders [25, 26]. In the general adult
population, about 40% of those who have depression or
anxiety at one time point, have been found to have at
least one of these disorders 7 years later [27]. Having a
disorder or mental health problems in adolescence in-
creases the risk of such disorders/problems in early
adulthood [18, 28–30]. Findings from the NCS follow-
up (NCS-2) showed that having MDD or generalized
anxiety disorder (GAD) in the twenties and thirties
predicted having any of these disorders eleven years
later [31]. Depression seems to be more episodic than
anxiety disorders among adolescents, as shown by
higher 12-month to 30-day prevalence ratios of mood
than anxiety disorders [22].
Comorbidity
Comorbidity between mental disorders is extensive with
up to 50% of those who have one mental disorder also
having at least one additional comorbid mental disorder
[4, 7, 32]. This is also reported among young people [33].
Comorbidity seems to a large degree to be due to com-
mon liablity factors for several disorders [34, 35] and is
related to severity and chronicity [27, 33, 36, 37]. Hence,
estimates of comorbidity in different developmental
periods may increase our understanding of the potential
effects of common mental disorders on young adults.
Need for further knowledge
Current knowledge on prevalence and stability of mental
disorders among young adults relies heavily on results
from the US and New Zealand. Longitudinal studies
from several different countries are needed to inform
policy makers in different parts of the world and to
estimate global disease burden in this age period.
Previous prevalence estiamtes of any mental disorder
or any anxiety disorder typically include specific phobias,
which by definiton involves imapirment in circum-
scribed situations and can sometimes be treated in a
single therapy session [38]. Prevalence estiamtes both
including and excluding such phobias are therefore
needed to plan mental health services for young adults.
Findings are divergent with regards to whether or not
anxiety disorders become less prevalent during young
adulthood. Previous studies have included different anx-
iety disorders when examining this. There is a lack of
studies tracking the episodic versus chronic nature of
MDD and anxiety disorders across young adulthood. If
depression tends to get more or less episodic over time,
the burden of recurrent depression will decrease or
increase as people get older. More knowledge about the
stability of anxiety disorders and MDD from the twen-
ties to the thirties/forties may increase our understand-
ing of the potential impact of such disorders on young
adult development. This is important for planning
mental health services for young adults.
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A limitation in several previous studies of AUD is
different diagnostic criteria across waves and use of alcohol
abuse as a screen for alcohol dependence [39]. This may
affect estimates of prevalence and stability of this disorder
[24, 39].
To the best of our knowledge, no previous studies have
examined prevalence and stablity in common mental dis-
orders by both: Following the same individuals from the
twenties to the thirties/forties, estimating prevalence of
anxiety disorders at the different ages including as well as
excluding specific phobias, comparing the episodic versus
chronic nature of disorders at both ages, and examining
comorbidity between disorders at both ages.
Aims of the study
The overall aim of the current study was to address limi-
tations in previous literature on prevalence and stability
of common mental disorders from the twenties to the
thirties/forties. More specifically, the aims were to: 1)
Estimate the 12-month prevalence of anxiety disorders
(with and without specific phobias), mood disorders,
and AUD among people aged 19 to 29, 2) Compare
these estimates to prevalence estimates ten years later, 3)
Compare 12-month to two-week prevalence estimates to
examine the episodic nature of disorders across these
two developmental periods, 4) Examine the degree to
which those who have an anxiety disorder or MDD in
the twenties, are at increased risk of having these disor-
ders ten years later, 5) Examine comorbidity of common




Data came from the Norwegian Institute of Public
Health Twin Panel (NIPHTP), which includes health
questionnaires at two time points (Q1 and Q2), and
diagnostic interviews at two later time points (wave 1
and wave 2). The current study used data from the two
interviews. The NIPHTP is described thoroughly else-
where [40–44], and recruitment is illustrated in Fig. 1.
The first wave of the interview study (wave 1) took place
between 1999 and 2004, and 2801 individuals (44% of the
invited) were interviewed. All twins who had participated
in wave 1 were invited for a re-interview between 2010
and 2011 (wave 2). The follow-up participation rate from
Fig. 1 Flow-chart of recruitment to the study. The current study used data from the two interview studies, indicated with bold font
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wave 1 to wave 2 was 82.8% (n = 2284) [41]. Mean age was
28.3 years (range 19–36 years) in wave 1 and 37.9 years
(range 30–44 years) in wave 2. Mean time between
interviews was 9.6 years (range 7–13 years). Participation
in wave 1 was predicted by increasing age and monozy-
gosity, but not by any indicator of mental health [42].
Participation in wave 2 was predicted by high education,
female sex, and monozygosity. Neither the total number
of mental disorders nor any specific disorder in wave 1
predicted participation in wave 2 [41].
The current study aimed to examine mental disorders
in a specific developmental period (19–29 years of age)
and follow these individuals over time. Hence, only
participants below age 30 in wave 1 were included in the
main analyses. This resulted in a sample of 597 men and
1026 women in wave 1, and 457 men and 850 women in
wave 2. Mean age in wave 1 was 25.4 years (range 19 to
29), and mean age in wave 2 was 35.3 years (range 30 to
42). Mean time between the two interviews was 9.6 years.
Prevalence estimates for the wider age range of the
entire sample were also calculated and are presented in
Additional file 1: Tables S1 and S2, for readers who are
interested in prevalence of mental disorders in a wider
age group.
Measures
A Norwegian version of the computerized Munich
Composite International Diagnostic Interview (M-CIDI),
originally developed by the World Health Organization,
was employed in both interview waves [45]. Diagnoses
were coded according to the Diagnostic and Statistical
Manual of Mental Disorders, Fourth Edition (DSM-IV).
The interview was mainly administered face-to-face in
wave 1. For practical reasons, 231 interviews (8.3%) were
conducted by telephone. To maximize response rate, all
the interviews were conducted by telephone in wave 2.
Interviewers were mostly psychology graduate students
or experienced psychiatric nurses who had received
standardized training by certified instructors. Each twin
in a pair was interviewed by a different interviewer.
Respondents answered one question about when they
last experienced symptoms of each of the disorders. The
response categories were “Within the last two weeks”,
“Two weeks to less than a month”, “One to five months”,
“6 to 12 months”, “Last 12 months, but cannot remem-
ber exactly when”, and “More than one year”. Endorse-
ment of the first option was used to estimate 2-week
prevalence, endorsement of any of the first two options
to estimate 4-week prevalence, endorsement of any of
the first three options to estimate 5(6) month-
prevalence, and endorsement of any of the first five
options to estimate 12-month-prevalence. Hence,
individuals contributing to two-week prevalence esti-
mates were a sub-group of those contributing to all
other prevalence estimates of each disorder.
Table 1 shows an overview of combined categories of
diagnoses. AUD consisted of alcohol abuse and alcohol
dependence. Any mood disorder consisted of MDD and
dysthymia. Any anxiety disorder W1 consisted of panic
disorder, agoraphobia without a history of panic dis-
order, specific phobias, social phobia, GAD, obsessive-
compulsive disorder (OCD), and post-traumatic stress
Table 1 Overview of disorders included in the combined categories
Combined category Includes Constructed for
wave
Any mood disorder MDD, Dysthymia 1 and 2
Any anxiety disorder W1 Panic disorder, Agoraphobia without a history of panic disorder, Specific phobias, Social
phobia, GAD, OCD, PTSD.
1
Any Anxiety disorder W1–2 Panic disorder, Agoraphobia without a history of panic disorder, Specific phobias, Social
phobia, GAD.
1 and 2
Any anxiety disorder W1–2 excluding
specific phobias
Panic disorder, Agoraphobia without a history of panic disorder, Social phobia, GAD. 1 and 2
AUD Alcohol abuse, Alcohol dependence. 1 and 2
Any mental disorder W1 Any mood disorder, Any anxiety disorder W1, AUD. 1
Any mental disorder W1–2 Any mood disorder, Any anxiety disorder W1–2, AUD. 1 and 2
Any mental disorder W1–2 excluding
specific phobias
Any mood disorder, Any anxiety disorder W1–2 excluding specific phobias, AUD. 1 and 2
Categories only presented in Supplementary table
Drug use disorder Drug abuse, drug dependence. 1
Any substance use disorder Drug use disorder, AUD. 1
Any disorder W1- supplement Any mood disorder, Any anxiety disorder W1, Any substance use disorder 1
Legends: MDD Major depressive disorder, GAD Generalized anxiety disorder, OCD Obsessive-compulsive disorder, PTSD Post-traumatic stress disorder, AUD Alcohol
use disorder
W1 Wave 1, W2 wave 2
Gustavson et al. BMC Psychiatry  (2018) 18:65 Page 4 of 15
disorder (PTSD). In wave 2, OCD and PTSD were not
assessed. These two disorders are no longer classified as
anxiety disorders in DSM-5 [46]. Any anxiety disorder
W1–2 did not include these two disorders, and was con-
structed for both waves to allow comparison of anxiety
disorders across age. Any anxiety disorder W1–2 exclud-
ing specific phobias consisted of all anxiety disorders
measured in both waves except specific phobias. Any
mental disorder W1 consisted of Any mood disorder,
Any anxiety disorder W1, and AUD. Any mental disorder
W1–2 consisted of Any mood disorder, Any anxiety dis-
order W1–2, and AUD. Any mental disorder W1–2
excluding specific phobias consisted of Any mood
disorder, Any anxiety disorder W1–2 excluding specific
phobias, and AUD.
Total as well as sex-stratified prevalence estimates are
presented for MDD, Any mood disorder, Any anxiety
disorder (W1, W1–2, as well as W1–2 excluding specific
phobias), AUD, and Any mental disorder (W1, W1–2,
and W1–2 excluding specific phobias). Prevalence
estimates for low frequent specific disorders (e.g. panic
disorders and dysthymia) are only presented for both
genders together. Drug use disorders (drug addiction
and drug abuse) were only assess in wave 1, and are
presented in Additional file 1: Table S1.
We report 12-month and 2-week prevalence estimates.
The other two measured prevalences (5(6)-month and
four-week) are presented in Additional file 1: Tables S1
and S2. Interested readers may use those estimates to
compare findings with other studies that have used
estimates between 12-month and two-week (as for
example [22, 47]).
Statistical analyses
Analyses were performed in Stata version 15. Testing all
the prevalence estimates for statistically significant
gender differences would imply a large number of tests,
thus increasing the risk of random findings. Such testing
was therefore only performed for the following
estimates: 12-month Any mental disorder W1–2, 12-
month Any mood disorder, 12-month Any anxiety
disorder W1–2, and 12-month AUD.
The 12-month and 2-week prevalence estimates were
compared for MDD and Any anxiety disorder W1–2.
Episodic disorders are expected to show higher 12-
month than 2-week prevalences whereas the prevalences
are expected to be more similar for more chronic
disorders.
Absolute stability was examined by comparing preva-
lence estimates at the two waves. Only those who partic-
ipated in wave 2, were included in significance testing of
change in prevalence estimates, thus reducing the risk of
bias du to potential selective attrition. Relative stability
refers to the degree to which it is the same or different
people who have a diagnosis across ages [48]. This was
examined with logistic regression for MDD, Any anxiety
disorder W1–2, and AUD, adjusted for age in wave 1.
We also examined the degree to which MDD in wave 1
predicted having Any anxiety disorder W1–2 in wave 2,
and vice versa, controlled for age. Because of low
number of cases and thus low statistical power, AUD
was not included. Men and women were collapsed in
these analyses to increase statistical power.
Comorbidity within each wave was examined with
tetrachoric correlations between MDD, Any anxiety
disorders W1–2, and AUD. Comorbidity was also exam-
ined by showing the proportion of people with one dis-
order, who also had another disorder, and by illustrating
how many of a hypothetical sample of 100 individuals
who would have either one disorder, or a combination of
two or three disorders. Men and women were collapsed.
The concordance between twins may affect results.
First, standard errors may be too small due to clustering
effects [49–51]. This was adjusted for by drawing
clusters (twin-pairs) rather than individuals in the
bootstrapping/jackknife process and by using the robust
estimator for standard errors in logistic regression [49–
51]. Second, sensitivity analyses were performed includ-




We report results for 597 men and 1026 women (63.2%)
who participated in wave 1 (Table 2) and 457 men and
850 women (65.0%) who also participated in wave 2
(Table 3).
In wave 1, when the participants were in the twen-
ties, Any anxiety disorder W1 was the most prevalent
combined category of disorders for both men and
women (see Table 2). The 12-month prevalence for
Any anxiety disorder W1 was 9.6% (95% confidence
interval (CI) = 7.0–12.4) for men and 26.7% (95% CI =
23.7–29.7) for women. For Any anxiety disorder W1–
2, the 12-month prevalence was 9.3 (95% CI = 7.0–
12.3) for men and 26.0% (95% CI = 23.1–29.0) for
women. AUD ranked second among men (8.7% 12-
month prevalence, 95% CI = 6.5–11.3), and Any mood dis-
order ranked second among women (8.7% 12-month
prevalence, 95% CI = 6.7–10.6). Specific phobias were
highly prevalent among men and women (12-month
prevalence = 7.6% with 95% CI = 5.5–10.2 for men and
22.3% with 95% CI = 19.5–25.0 for women). AUD and Any
mood disorder were the most common groups of disorders
for men, and Any mood disorder was the most common
group of disorders for women when specific phobias were
excluded. Results from significance testing of gender
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difference showed that Any mental disorder W1–2, Any
anxiety disorder W1–2, and Any mood disorder were more
prevalent among women than men, while AUD was more
prevalent among men than women (see Table 2).
In wave 2, the 12-month prevalence of Any anxiety
disorder W1–2 was 5.9% (95% CI = 4.0–8.2) for men and
21.6% (95% CI = 18.6–24.6) for women (see Table 3).
Again, this was mainly due to the high prevalence of
specific phobias (12-month prevalence was 4.1% with
95% CI = 2.4–6.1 for men and 16.8% with 95% CI =
14.1–19.5 for women). Any mood disorder was the
second most prevalent group of disorders among
women (12-month prevalence 7.0% with 95% CI =
5.3–8.7), and AUD was the second most common dis-
order among men (12-month prevalence = 5.3% with
95% CI = 3.2–7.2). Any mental disorder W1–2, Any
mood disorder, and Any anxiety disorder W1–2, were
more prevalent among women than men, and the re-
verse was true for AUD (see Table 3).
Stability
There was a reduction in Any mental disorder W1–2,
Specific phobias, and AUD from wave 1 to wave 2
(95% CI for differences did not include zero). Estimates
were stable for MDD and Any anxiety disorder W1–2
excluding specific phobias (95% CI for difference included
zero).
Relative stability was measured with logistic regression,
presented in Table 4. Having MDD, Any anxiety disorder
W1–2, or AUD in the twenties, increased the risk of
having these disorders ten years later. The results
showed that Any anxiety disorder W1–2 in wave 1 pre-
dicted MDD in wave 2, even controlled for MDD in
wave 1.
Despite relative stability from wave 1 to wave 2, 82.4%
of those who had MDD, 54.9% of those who had Any
anxiety disorder W1–2, and 85.4% of those who had
AUD in Wave 1 (12-mont prevalence), did not have the
same disorder in wave 2.
12-month versus 2-week prevalence estimates
The 12-month prevalence of MDD was significantly
higher than the 2-week prevalence in both waves. The
12-month to two-week ratios for MDD was 4.8 (95% CI
= 3.9–7.5) in wave 1 and 4.6 (95% CI = 3.1–8.6) in wave
2. For Any anxiety disorder W1–2 the ratios were 1.3
(95% CI = 1.3–1.4) in wave 1 and 1.9 (95% CI = 1.7–2.2)
in wave 2, indicating a more episodic nature of MDD
than anxiety disorders.
Comorbidity
Tetrachoric correlations between 12-month MDD, Any
anxiety disorder W1–2, and AUD within each wave are
presented in Table 5. There was a strong association be-
tween MDD and Any anxiety disorder W1–2 in both
waves.
Comorbidity was also examined by calculating how
many of those who had one disorder, also had another
disorder. The results are presented in Table 6. The co-
morbidity numbers for AUD should be interpreted with
caution in wave 2, as few people had this diagnosis.
Figure 2 shows the number of people with pure versus
comorbid MDD, Any anxiety disorder W1–2, and AUD
in hypothetical samples of 100 men and 100 women in
the twenties and in the thirties/forties.
Table 4 Relative stability in mental disorders from age 19–29 to
age 30–42 estimated with logistic regression




MDD and Anxiety in
W1 mutually adjusted
for each other OR
(95% CI)
MDD in wave 2








Anxiety in wave 2








AUD in wave 2 8.10***
AUD in wave 1 (3.69–17.76)
Legends: OR Odds ratio, CI Confidence interval, MDD Major depressive disorder,
Anxiety = Any anxiety disorder W1–2 (Panic disorder, agoraphobia without
panic, specific phobias, social phobia and/or generalized anxiety disorder
(GAD)). Standard errors were obtained from the robust estimator in Stata,
accounting for cluster-effects among twins
Men and women were collapsed in the analyses to increase statistical power.
All analyses were adjusted for age in wave 1
Table 5 Tetrachoric correlations between different disorders at
wave 1 (age 19–29) and wave 2 (age 30–42)






Wave 1 MDD 0.45*** 0.00 0.31** 0.38*** 0.16
Anxiety W1–2a 0.10 0.26** 0.65*** 0.02
AUD 0.07 0.07 0.49***
Wave 2 MDD 0.54*** 0.12
Anxiety W1–2a 0.03
AUD
Legends: aPanic disorder, agoraphobia without panic, specific phobias, social
phobia and/or generalized anxiety disorder (GAD)
MDD Major depressive disorder. AUD Alcohol use disorders, i.e. alcohol
dependence or alcohol abuse. Standard errors were obtained from the
jackknife estimator, accounting for cluster-effects among twins. **p < 0.01,
***p < 0.001. Men and women were collapsed to increase statistical power
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Sensitivity analyses of concordance between twins
As mentioned in the methods section, the use of twins
may have affected results, and sensitivity analyses were
therefore performed. If one twin did not have any
mental disorder during the last 12 months in wave 1, the
co-twin’s risk of having a mental disorder was 21.7%
(compared to 27.8% in the full sample). When one twin
had a mental disorder, the co-twin’s risk was 43.7%. This
concordance between twins was expressed in an intra-
class correlation of 0.21. Prevalence of MDD, Any
anxiety disorders W1, AUD, and Any mental disorder
W1 were estimated for a sub-sample where one twin
was randomly chosen from each pair (see Table 7). The
estimates were quite similar to estimates from both
twins. The ratio of the results (estimates from the entire
sample/estimates from only one twin) varied between
1.00 and 1.04.
Discussion
MDD, anxiety disorders, and AUD were highly prevalent
at age 19–29. The prevalence of mental disorders was
lower at age 30–42, and this was mainly due to decrease
Table 6 Comorbidity wave 1 (age 19–29) and wave 2 (age 30–42)
Men Women




























































Legends: MDD Major depressive disorder, AUD Alcohol use disorders, i.e. alcohol dependence or alcohol abuse
aPanic disorder, agoraphobia without panic, specific phobias, social phobia and/or generalized anxiety disorder (GAD)
Fig. 2 Combinations of disorders in hypothetical groups of 100 men and 100 women at different ages. Legend: MDD =major depressive
disorder, Anxiety = Any anxiety disorder W1–2 (Panic disorder, agoraphobia without panic, specific phobias, social phobia and/or generalized
anxiety disorder (GAD)), AUD = alcohol use disorder (i.e. alcohol dependence and alcohol abuse)
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in AUD and specific phobias. Prevalence estimates of
MDD and anxiety disorders excluding specific phobias
were stable in this period. Individuals who had MDD, an
anxiety disorder, or AUD in the twenties were of in-
creased risk of having these disorders in the thirties/for-
ties compared to those who did not have these
diagnoses in the twenties.
Prevalence estimates
The 12-month prevalence of depressive disorders in
people in the twenties was lower in the current study
compared to young adults in the CICS [16], the Dunedin
study, NZMHS, NCS, and NCS-R [21, 23], but similar to
the prevalence among 26-year-olds in the Simmons longi-
tudinal study [24]. The current findings were very similar
to results from these other studies with regard to preva-
lence of anxiety disorders in the twenties. In the Dunedin
study, alcohol dependence among people aged 18 to
32 years was more prevalent than the broader category of
AUD in both waves in the current study [21]. Likewise,
the narrower category alcohol abuse was more prevalent
in TRAILS and NCS-R than AUD in the current sample
[22, 23]. In the Simmons longitudinal study, the preva-
lence of AUD was similar to the current results [24].
Our findings are in line with previous studies showing
that anxiety disorders tend to be the most prevalent
group of disorders, both in the general adult population
and among young adults [21, 52]. The current results
are in line with previous Norwegian findings of higher
prevalence of specific phobias compared to international
studies [6, 53].
The most prevalent groups of disorders were mood disor-
ders and AUD among men and mood disorders among
women when specific phobias were excluded. Such phobias
are very common, but by definiton highly situation-specific.
The current results allowed differentiating between this
very circumscrbied disorder and mental disorders that
affect people in more complex ways across different situa-
tions (e.g. MDD, GAD, and AUD).
Stability
Mental disorders became less prevalent as participants
went from the twenties to the thirties/forties. Our results
converge with findings from the Simmons Longitudinal
study regarding a decrease in specific phobias and AUD
[24]. Other anxiety disorders did not become less preva-
lent in the current study. Findings from the Dunedin
study showed a marked decrease in acohol dependence,
and quite stable prevalence of MDD and anxiety disorders
(including specific phobias, GAD, panic disorder, agora-
phobia, OCD, and PTSD) from age 21 to age 32 [21]. De-
crease in AUD across young adulthood may reflect the
circumstances of people in the twenties, who often do not
have responsibility for children, and many are students.
Results from a previous study indicate that a third of
those who met diagnostic criteria for AUD in late ado-
lescence, also met criteria for AUD at age 26 [54]. In the
current study, only about 15% of those who met diag-
nostic criteria for AUD in the twenties also had AUD in
the thirties/forties. Hence, the course of AUD seems to
be less chronic from the twenties to the thirties/forties
than from late adolescence to age 26. Nevertheless, the
current results showed that those who had AUD in the
twenties, had increased risk of having AUD in the thir-
ties/forties compared to those who did not have AUD in
the twenties.
Previous studies have found that the majority of indi-
viduals with anxiety and depressive disorders at one time
point are free from these disorders after three to 11 years
[25–27, 55]. This was also the case in the current study.
However, those who had MDD or anxiety disorders in
the twenties, had increased risk of having these disorders
Table 7 Prevalence estimates in wave 1 when using both twins versus one twin in each pair
12-month prevalence estimate
using both twins 95% CIc
12-month prevalence estimate
only including one twin from
each pair 95% C.I.
Ratio
Entire sample estimate/






















Legends: CI Confidence interval, MDD Major depressive disorder
aPanic disorder, agoraphobia without panic, specific phobias, social phobia, generalized anxiety disorder (GAD), obsessive-compulsive disorder (OCD), and/or post--
traumatic stress disorder (PTSD)
AUD Alcohol use disorders, i.e. alcohol dependence or alcohol abuse
bAny mental disorder W1 = Any mood disorder, Any anxiety disorder W1, AUD
c95% CIs are based on standard errors obtained from bootstrapping (1000 replications), bias corrected for skewness in the bootstrap distribution, and adjusted for
cluster-effects among twins
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in the thirties/forties compared to those who did not
have the disorders in the twenties. This is in line with
previous findings from a wider age group of adults (age
18 to 65 at baseline) [56].
Anxiety disorders in the twenties strongly predicted
MDD ten years later, even controlling for MDD in the
twenties, in line with findings of stable and unspecific
genetic risk of mental disorders [34, 35, 57]. The associ-
ation between MDD in the twenties and anxiety
disorders in the thirties/forties, controlled for anxiety
disorders in the twenties, was not statistically significant,
which may be due to low statistical power. However,
others have reported similar results by showing that
baseline GAD predicted persistence of MDD, but not
the other way around among adolescents and young
adults in the NCS-2 [31]. This is also in line with other
longitudinal findings from the general adult population,
showing that anxiety at one time point predicted depres-
sion at a later time to a stronger degree than the reverse
[58]. In the Netherlands Mental Health Survey and Inci-
dence Study (NEMESIS), mood disorder at follow-up
was predicted by anxiety disorders three years earlier,
and incident anxiety disorder was predicted by previous
mood disorders [59]. In the US National Epidemiological
Survey on Alcohol and Related Conditions (NESARC),
there was reciprocal longitudinal associations between
incidence of MDD and GAD [60]. The Finnish Health
2011 study reported that baseline anxiety disorder
predicted new-onset MDD at 11-year follow-up [61].
Hence, anxiety disorders and MDD seem to have
common risk factors, but it is unclear whether anxiety is
a more robust predictor of later MDD than the reverse.
MDD seemed to be more episodic in its nature than
anxiety disorders, in line with previous studies [22, 55].
There was no change toward a more or less chronic course
of any of these disorders when the participants got older.
Comorbidity
There was substantial comorbidity between disorders
within each wave, in line with previous research [4, 7,
32, 37], and no evidence of increased or decreased co-
morbidity between MDD and anxiety disorders from the
twenties to the thirties/forties. In both waves, more than
half of women and about one third of men with MDD,
also had an anxiety disorder. Among those who had an
anxiety disorder, one in five or fewer, also had MDD.
Young people with vulnerability of both MDD and anx-
iety, may at any time point have higher risk of experien-
cing a current anxiety disorder than current MDD
because the latter disorder tends to be more episodic.
Implications for policy makers
Previous research has shown that most people with
mental disorders go untreated [62, 63]. The current
results highlight the need to make adequate treatment
easily available for young adults, to help them cope with
their developmental tasks (e.g. attain education and
work experience). Easily available treatment is important
because of the high prevalence of mental disorders in
the twenties and the thirties/forties, and because these
disorders were long lasting and/or recurrent across ten
years for a substantial number of young adults.
The high prevalence of AUD between age 19 and 29
suggests that it is important to implement alcohol inter-
ventions particularly tailored to fit this age group and
their often-changing life circumstances. Specific phobias
may impose functional impairment only in particular
situations, but may be serious if those situations are
difficult to avoid. There seems to be a particularly high
need for efficient treatment of specific phobias for
people in the twenties.
Other anxiety disorders and MDD did not become less
prevalent with age. Anxiety disorders and MDD did not
become more episodic from the twenties to the thirties/
forties, and comorbidity between them did not change
during this period. Hence, mental health needs for other
disorders than AUD and specific phobias are stable from
the twenties to the thirties/forties, and many young
adults will need treatment for more than one mental
disorder.
As noted by Schaefer and colleagues, public knowledge
about the very common nature of mental disorders may
contribute to reduced stigma [64]. In line with this, pub-
lic information about the current findings of high preva-
lence of mental disorders among young adults may
contribute to reduced stigma in this age group.
Strengths and limitations
The major strength of the present study is the large
population-based sample, which has been assessed twice
across 10 years for DSM-IV disorders by structured in-
terviews. However, some limitations warrant consider-
ation. First, the results may not be generalizable to other
age groups. Second, there may be bias in the results due
to selection in recruitment and attrition at follow-up.
People with mental health problems tend to be under-
represented in survey studies [65]. However, as discussed
above, mental health variables did not predict participa-
tion in either of the interview waves [41, 42], and bias
due to selective response may thus not be substantial.
Third, the results are based on a sample of twins,
which may reduce generalizability to the general popula-
tion. A study from the US compared self-reported symp-
toms of depression, panic-phobia, somatization, and
insomnia between twins and their non-twin relatives,
and found that twins had significantly, but modestly,
higher scores on the panic-phobia factor, but reported
similar levels of psychiatric symptoms as their non-twin
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relatives on the other factors [66]. The authors con-
cluded that “twins are typical for the general non-twin
population in their risk for psychiatric symptoms and
syndromes.” (p. 590). Nevertheless, the current findings
may be affected by the fact that two individuals from each
family were recruited to the study. There was substantial
concordance between two twins in a pair regarding mental
disorders. Sensitivity analyses were performed with only
one twin from each pair included, and results were very
similar to the results from both twins.
Conclusion
Mental disorders are common among young people in
the twenties and the thirties/forties, but AUD and
specific phobias seem to become less prevalent over this
age period. Nevertheless, some people are at enduring
increased risk of impaired functioning due to mental
disorders in consecutive developmental periods. Policy
makers should ensure that mental health interventions
are available and tailored for young people to help them
master their developmental tasks.
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